Literature DB >> 20019115

Lack of association between dialysis modality and outcomes in atheroembolic renal disease.

Pietro Ravani1, Rossella Gaggi, Cristiana Rollino, Marisa Santostefano, Nevio Stabellini, Loredana Colla, Nadia Dallera, Sara Ravera, Sergio Bove, Pompilio Faggiano, Francesco Scolari.   

Abstract

BACKGROUND AND OBJECTIVES: Atheroembolic renal disease (AERD) can require dialytic support. Because anticoagulation may trigger atheroembolization, peritoneal dialysis may be preferred to hemodialysis. However, the effect of dialysis modality on renal and patient outcomes in AERD is unknown. DESIGN, SETTINGS, PARTICIPANTS, & MEASUREMENTS: A subcohort of 111 subjects who developed acute/subacute renal failure requiring dialysis was identified from a larger longitudinal study of AERD. The main exposure of interest was dialysis modality (peritoneal versus extracorporeal therapies). Logistic regression was used to study the probability of renal function recovery. Times from dialysis initiation to death were studied using Cox's regression.
RESULTS: Eighty-six patients received hemodialysis and 25 received peritoneal dialysis. The probability of renal function recovery was similar by dialysis modality (25% among hemodialysis patients and 24% among peritoneal dialysis patients; P = 0.873). During follow-up, 58 patients died, 14 among peritoneal patients and 44 among hemodialysis patients (P = 0.705). In multivariable analysis, gastrointestinal tract involvement and use of statins maintained an independent effect on the risk of patient death.
CONCLUSIONS: This study does not support the notion that one dialysis modality is superior to the other. However, the observational nature of the data precludes any firm conclusions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20019115      PMCID: PMC2827570          DOI: 10.2215/CJN.06590909

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  16 in total

Review 1.  Cholesterol crystal embolism: A recognizable cause of renal disease.

Authors:  F Scolari; R Tardanico; R Zani; A Pola; B F Viola; E Movilli; R Maiorca
Journal:  Am J Kidney Dis       Date:  2000-12       Impact factor: 8.860

Review 2.  Cholesterol embolization syndrome induced by thrombolytic therapy.

Authors:  Wassim A Hitti; Ravinder K Wali; Edward J Weinman; Edward J Weiman; Cinthia Drachenberg; Andrew Briglia
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

3.  Peritoneal dialysis in acute renal failure due to cholesterol embolization: two cases of recovery of renal function and extended survival.

Authors:  L Siemons; P van den Heuvel; G Parizel; N Buyssens; M E De Broe; J J Cuykens
Journal:  Clin Nephrol       Date:  1987-10       Impact factor: 0.975

4.  Cholesterol embolization. From pathological curiosity to clinical entity.

Authors:  M Moldveen-Geronimus; J C Merriam
Journal:  Circulation       Date:  1967-05       Impact factor: 29.690

Review 5.  Cholesterol crystal embolization: a review of 221 cases in the English literature.

Authors:  M J Fine; W Kapoor; V Falanga
Journal:  Angiology       Date:  1987-10       Impact factor: 3.619

Review 6.  Cholesterol embolisation after thrombolytic therapy.

Authors:  J C Blankenship
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

7.  Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study.

Authors:  Francesco Scolari; Pietro Ravani; Alessandra Pola; Simona Guerini; Roberto Zubani; Ezio Movilli; Silvana Savoldi; Fabio Malberti; Rosario Maiorca
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

Review 8.  Renal cholesterol embolic disease. Case report and review of the literature.

Authors:  W C Lye; J S Cheah; R Sinniah
Journal:  Am J Nephrol       Date:  1993       Impact factor: 3.754

9.  Warfarin-related purple toes syndrome and cholesterol microembolization.

Authors:  B T Hyman; S K Landas; R F Ashman; R L Schelper; R A Robinson
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

Review 10.  Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases.

Authors:  Josée Thériault; Mohsen Agharazzi; Marc Dumont; Vincent Pichette; Denis Ouimet; Martine Leblanc
Journal:  Nephron Clin Pract       Date:  2003
View more
  1 in total

1.  Anti-neutrophil cytoplasmic antibodies in cholesterol embolism: A case report and literature review.

Authors:  Jun Zhang; Heng-Yuan Zhang; Shi-Zhi Chen; Ji-Yi Huang
Journal:  Exp Ther Med       Date:  2016-05-17       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.